Pharma & Healthcare

Global Sorafenib Market Research Report 2025

Report Scope
This report aims to provide a comprehensive presentation of the global market for Sorafenib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sorafenib.
The Sorafenib market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sorafenib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sorafenib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Bayer
Natco Pharma
Cipla
Mylan
Segment by Type
Patented Drugs
Generic Drugs
Segment by Application
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
Consumption by Region
North America
the United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
UK
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sorafenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sorafenib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 Sorafenib Market Overview
1.1 Product Definition
1.2 Sorafenib by Type
1.2.1 Global Sorafenib Market Value Comparison by Type (2024 VS 2031)
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Sorafenib by Application
1.3.1 Global Sorafenib Market Value by Application (2024 VS 2031)
1.3.2 Kidney Cancer
1.3.3 Liver Cancer
1.3.4 Thyroid Cancer
1.3.5 Other
1.4 Global Sorafenib Market Size Estimates and Forecasts
1.4.1 Global Sorafenib Revenue 2020-2031
1.4.2 Global Sorafenib Sales 2020-2031
1.4.3 Global Sorafenib Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sorafenib Market Competition by Manufacturers
2.1 Global Sorafenib Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sorafenib Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sorafenib Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sorafenib, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sorafenib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sorafenib, Product Type & Application
2.7 Global Key Manufacturers of Sorafenib, Date of Enter into This Industry
2.8 Global Sorafenib Market Competitive Situation and Trends
2.8.1 Global Sorafenib Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sorafenib Players Market Share by Revenue
2.8.3 Global Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sorafenib Market Scenario by Region
3.1 Global Sorafenib Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sorafenib Sales by Region: 2020-2031
3.2.1 Global Sorafenib Sales by Region: 2020-2025
3.2.2 Global Sorafenib Sales by Region: 2026-2031
3.3 Global Sorafenib Revenue by Region: 2020-2031
3.3.1 Global Sorafenib Revenue by Region: 2020-2025
3.3.2 Global Sorafenib Revenue by Region: 2026-2031
3.4 North America Sorafenib Market Facts & Figures by Country
3.4.1 North America Sorafenib Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sorafenib Sales by Country (2020-2031)
3.4.3 North America Sorafenib Revenue by Country (2020-2031)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Sorafenib Market Facts & Figures by Country
3.5.1 Europe Sorafenib Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sorafenib Sales by Country (2020-2031)
3.5.3 Europe Sorafenib Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sorafenib Market Facts & Figures by Region
3.6.1 Asia Pacific Sorafenib Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sorafenib Sales by Region (2020-2031)
3.6.3 Asia Pacific Sorafenib Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sorafenib Market Facts & Figures by Country
3.7.1 Latin America Sorafenib Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sorafenib Sales by Country (2020-2031)
3.7.3 Latin America Sorafenib Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sorafenib Market Facts & Figures by Country
3.8.1 Middle East and Africa Sorafenib Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sorafenib Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sorafenib Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sorafenib Sales by Type (2020-2031)
4.1.1 Global Sorafenib Sales by Type (2020-2025)
4.1.2 Global Sorafenib Sales by Type (2026-2031)
4.1.3 Global Sorafenib Sales Market Share by Type (2020-2031)
4.2 Global Sorafenib Revenue by Type (2020-2031)
4.2.1 Global Sorafenib Revenue by Type (2020-2025)
4.2.2 Global Sorafenib Revenue by Type (2026-2031)
4.2.3 Global Sorafenib Revenue Market Share by Type (2020-2031)
4.3 Global Sorafenib Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sorafenib Sales by Application (2020-2031)
5.1.1 Global Sorafenib Sales by Application (2020-2025)
5.1.2 Global Sorafenib Sales by Application (2026-2031)
5.1.3 Global Sorafenib Sales Market Share by Application (2020-2031)
5.2 Global Sorafenib Revenue by Application (2020-2031)
5.2.1 Global Sorafenib Revenue by Application (2020-2025)
5.2.2 Global Sorafenib Revenue by Application (2026-2031)
5.2.3 Global Sorafenib Revenue Market Share by Application (2020-2031)
5.3 Global Sorafenib Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Sorafenib Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Sorafenib Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Natco Pharma
6.2.1 Natco Pharma Company Information
6.2.2 Natco Pharma Description and Business Overview
6.2.3 Natco Pharma Sorafenib Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Natco Pharma Sorafenib Product Portfolio
6.2.5 Natco Pharma Recent Developments/Updates
6.3 Cipla
6.3.1 Cipla Company Information
6.3.2 Cipla Description and Business Overview
6.3.3 Cipla Sorafenib Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Cipla Sorafenib Product Portfolio
6.3.5 Cipla Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Company Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Sorafenib Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Sorafenib Product Portfolio
6.4.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sorafenib Industry Chain Analysis
7.2 Sorafenib Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sorafenib Production Mode & Process Analysis
7.4 Sorafenib Sales and Marketing
7.4.1 Sorafenib Sales Channels
7.4.2 Sorafenib Distributors
7.5 Sorafenib Customer Analysis
8 Sorafenib Market Dynamics
8.1 Sorafenib Industry Trends
8.2 Sorafenib Market Drivers
8.3 Sorafenib Market Challenges
8.4 Sorafenib Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sorafenib Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Sorafenib Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Sorafenib Market Competitive Situation by Manufacturers in 2024
Table 4. Global Sorafenib Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Sorafenib Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Sorafenib Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Sorafenib Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Sorafenib Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Sorafenib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sorafenib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sorafenib, Product Type & Application
Table 12. Global Key Manufacturers of Sorafenib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sorafenib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sorafenib as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sorafenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Sorafenib Sales by Region (2020-2025) & (K Units)
Table 18. Global Sorafenib Sales Market Share by Region (2020-2025)
Table 19. Global Sorafenib Sales by Region (2026-2031) & (K Units)
Table 20. Global Sorafenib Sales Market Share by Region (2026-2031)
Table 21. Global Sorafenib Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Sorafenib Revenue Market Share by Region (2020-2025)
Table 23. Global Sorafenib Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Sorafenib Revenue Market Share by Region (2026-2031)
Table 25. North America Sorafenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Sorafenib Sales by Country (2020-2025) & (K Units)
Table 27. North America Sorafenib Sales by Country (2026-2031) & (K Units)
Table 28. North America Sorafenib Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Sorafenib Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Sorafenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Sorafenib Sales by Country (2020-2025) & (K Units)
Table 32. Europe Sorafenib Sales by Country (2026-2031) & (K Units)
Table 33. Europe Sorafenib Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Sorafenib Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Sorafenib Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Sorafenib Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Sorafenib Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Sorafenib Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Sorafenib Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Sorafenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Sorafenib Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Sorafenib Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Sorafenib Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Sorafenib Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Sorafenib Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Sorafenib Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Sorafenib Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Sorafenib Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Sorafenib Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Sorafenib Sales (K Units) by Type (2020-2025)
Table 51. Global Sorafenib Sales (K Units) by Type (2026-2031)
Table 52. Global Sorafenib Sales Market Share by Type (2020-2025)
Table 53. Global Sorafenib Sales Market Share by Type (2026-2031)
Table 54. Global Sorafenib Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Sorafenib Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Sorafenib Revenue Market Share by Type (2020-2025)
Table 57. Global Sorafenib Revenue Market Share by Type (2026-2031)
Table 58. Global Sorafenib Price (USD/Unit) by Type (2020-2025)
Table 59. Global Sorafenib Price (USD/Unit) by Type (2026-2031)
Table 60. Global Sorafenib Sales (K Units) by Application (2020-2025)
Table 61. Global Sorafenib Sales (K Units) by Application (2026-2031)
Table 62. Global Sorafenib Sales Market Share by Application (2020-2025)
Table 63. Global Sorafenib Sales Market Share by Application (2026-2031)
Table 64. Global Sorafenib Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Sorafenib Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Sorafenib Revenue Market Share by Application (2020-2025)
Table 67. Global Sorafenib Revenue Market Share by Application (2026-2031)
Table 68. Global Sorafenib Price (USD/Unit) by Application (2020-2025)
Table 69. Global Sorafenib Price (USD/Unit) by Application (2026-2031)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Bayer Sorafenib Product
Table 74. Bayer Recent Developments/Updates
Table 75. Natco Pharma Company Information
Table 76. Natco Pharma Description and Business Overview
Table 77. Natco Pharma Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Natco Pharma Sorafenib Product
Table 79. Natco Pharma Recent Developments/Updates
Table 80. Cipla Company Information
Table 81. Cipla Description and Business Overview
Table 82. Cipla Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cipla Sorafenib Product
Table 84. Cipla Recent Developments/Updates
Table 85. Mylan Company Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Sorafenib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Mylan Sorafenib Product
Table 89. Mylan Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Sorafenib Distributors List
Table 93. Sorafenib Customers List
Table 94. Sorafenib Market Trends
Table 95. Sorafenib Market Drivers
Table 96. Sorafenib Market Challenges
Table 97. Sorafenib Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report


List of Figures
Figure 1. Product Picture of Sorafenib
Figure 2. Global Sorafenib Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sorafenib Market Share by Type: 2024 & 2031
Figure 4. Patented Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Sorafenib Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Sorafenib Market Share by Application: 2024 & 2031
Figure 8. Kidney Cancer
Figure 9. Liver Cancer
Figure 10. Thyroid Cancer
Figure 11. Other
Figure 12. Global Sorafenib Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Sorafenib Market Size (2020-2031) & (US$ Million)
Figure 14. Global Sorafenib Sales (2020-2031) & (K Units)
Figure 15. Global Sorafenib Average Price (USD/Unit) & (2020-2031)
Figure 16. Sorafenib Report Years Considered
Figure 17. Sorafenib Sales Share by Manufacturers in 2024
Figure 18. Global Sorafenib Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Sorafenib Players: Market Share by Revenue in Sorafenib in 2024
Figure 20. Sorafenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Sorafenib Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Sorafenib Sales Market Share by Country (2020-2031)
Figure 23. North America Sorafenib Revenue Market Share by Country (2020-2031)
Figure 24. the United States Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Sorafenib Sales Market Share by Country (2020-2031)
Figure 27. Europe Sorafenib Revenue Market Share by Country (2020-2031)
Figure 28. Germany Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. UK Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Sorafenib Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Sorafenib Revenue Market Share by Region (2020-2031)
Figure 35. China Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Sorafenib Sales Market Share by Country (2020-2031)
Figure 45. Latin America Sorafenib Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Sorafenib Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Sorafenib Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Sorafenib Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Sorafenib by Type (2020-2031)
Figure 55. Global Revenue Market Share of Sorafenib by Type (2020-2031)
Figure 56. Global Sorafenib Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Sorafenib by Application (2020-2031)
Figure 58. Global Revenue Market Share of Sorafenib by Application (2020-2031)
Figure 59. Global Sorafenib Price (USD/Unit) by Application (2020-2031)
Figure 60. Sorafenib Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies